Komori
Presentation materials for financial results9267Genky DrugStores Co.,Ltd.Retail

Supplementary Materials for the Fiscal Year Ending June 2026 Financial Results Briefing

The materials present numerical tables for results for the fiscal year ending June 2026 and the forecast for the fiscal year ending June 2027, covering sales and profit, store expansion, and expense breakdowns. Compared with the revised forecast, actual revenue, operating profit and ordinary profit for the fiscal year ending June 2026 were slightly lower, while net income was higher.

Worth reading
74In focus
Scored from 3 of 6 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Contents of this document

Supplementary materials to the earnings reportFull fiscal year ended June 20265 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥220,639 million+9.9%
Operating profit¥10,985 million+13.7%
Ordinary income¥11,158 million+12.7%
Net income¥7,875 million+11.4%
Selling, general and administrative expenses¥33,939 million
Gross Profit Margin
Rate20.36%
Operating profit margin
Rate5.0%
Results for the three months of the current quarter
Fourth quarter of the fiscal year ending June 2026
Net Sales
¥58,929 million
Operating profit
¥2,963 million
Ordinary income
¥2,989 million
Net income
¥2,254 million
Full-year earnings forecast
Fiscal year ending June 2027
Net Sales
¥244,000 million
Gross profit
¥49,900 million
Selling, general and administrative expenses
¥37,900 million
Operating profit
¥12,000 million
Ordinary income
¥12,100 million
Net income
¥8,200 million
What the company explained in this material
Key KPIsA metric the company considers important as a management benchmark.
  • Same-store sales (SSS)+2.9%
  • Total number of stores534 Location
  • Average sales-floor area162,955 tsubo
  • Sales per tsubo¥1,354 thousand/tsubo/year
  • Operating profit per tsubo¥67 thousand/tsubo/year
Number of stores and locations
Number of Stores at Period-End534 Location
Store openings57 Location
Number of store closures3 Location
Number of renovations8 Location
Capital expenditures
¥20,278 million
Annual Dividend
Annual dividend per share¥13
Payout ratio
Rate5.0%
Contents of this document
ItemDetails
Document typeSupplementary materials to the earnings report
Fiscal Period CoveredFull fiscal year ended June 2026
Net Sales¥220,639 million (YoY +9.9%)
Operating profit¥10,985 million (YoY +13.7%)
Ordinary income¥11,158 million (YoY +12.7%)
Net income¥7,875 million (YoY +11.4%)
Gross Profit MarginRate 20.36% / Year-on-year change (points) Not disclosed
Operating profit marginRate 5.0% / Year-on-year change (points) Not disclosed
Selling, general and administrative expenses¥33,939 million
Results for the three months of the current quarterSubject Fourth quarter of the fiscal year ending June 2026 / Net Sales ¥58,929 million / Operating profit ¥2,963 million / Ordinary income ¥2,989 million / Net income ¥2,254 million
Full-year earnings forecastSubject Fiscal year ending June 2027 / Net Sales ¥244,000 million / Gross profit ¥49,900 million / Selling, general and administrative expenses ¥37,900 million / Operating profit ¥12,000 million / Ordinary income ¥12,100 million / Net income ¥8,200 million
Key KPIsIndicator name Same-store sales (SSS) / Value +2.9% / Year on year against the same period last year Not disclosed, Indicator name Total number of stores / Value 534 Location / Year on year against the same period last year Not disclosed, Indicator name Average sales-floor area / Value 162,955 tsubo / Year on year against the same period last year Not disclosed, Indicator name Sales per tsubo / Value ¥1,354 thousand/tsubo/year / Year on year against the same period last year Not disclosed, Indicator name Operating profit per tsubo / Value ¥67 thousand/tsubo/year / Year on year against the same period last year Not disclosed
Number of stores and locationsNumber of Stores at Period-End 534 Location / Store openings 57 Location / Number of store closures 3 Location / Number of renovations 8 Location
Annual DividendAnnual dividend per share ¥13 / Interim Dividend Not disclosed / Year-end dividend Not disclosed
Payout ratioRate 5.0% / Total payout ratio Not disclosed / DOE Not disclosed
Capital expenditures¥20,278 million
Items this document does not state (15)
Progress against full-year forecastSelf-assessment against the planSegment resultsBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&ANew initiatives

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company explained that its forecast for net income for the fiscal year ending June 2027 incorporates the impact of being ineligible for tax credits under the tax incentive for promoting wage increases, as well as the impact of the special defense corporate tax. No specific reasons were provided for the differences between actual results for the fiscal year ending June 2026 and the revised forecast.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Materials for the Fiscal Year Ending June 2026 Financial Results Briefing | Genky DrugStores Co.,Ltd. (9267) timely disclosure | Komori